Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H13N3O5 |
Molecular Weight | 243.2166 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
InChI
InChIKey=UHDGCWIWMRVCDJ-CCXZUQQUSA-N
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1
Molecular Formula | C9H13N3O5 |
Molecular Weight | 243.2166 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:40:24 UTC 2023
by
admin
on
Sat Dec 16 16:40:24 UTC 2023
|
Record UNII |
04079A1RDZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L01XY01
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
234806
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
NDF-RT |
N0000175595
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
NDF-RT |
N0000000233
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DEPOCYT (AUTHORIZED: MENINGEAL NEOPLASMS)
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
265808
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
NCI_THESAURUS |
C1557
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
73393
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
LIVERTOX |
NBK548291
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
WHO-ATC |
L01BC01
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/11/942
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
||
|
WHO-VATC |
QL01BC01
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
968804
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
ALTERNATIVE | |||
|
205-705-9
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
DTXSID3022877
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
DB00987
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
SUB06880MIG
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
C408
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
3041
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
04079A1RDZ
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
m4051
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
6253
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
CYTARABINE
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL803
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
1162002
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
04079A1RDZ
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
4827
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
770
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
147-94-4
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
D003561
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
28680
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
100000089874
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
1709
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
3049
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY | |||
|
287459
Created by
admin on Sat Dec 16 16:40:27 UTC 2023 , Edited by admin on Sat Dec 16 16:40:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
kcat
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Km
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE INACTIVE -> PARENT |
Produced via Cytidine deaminase exposure.
PLASMA
|
||
|
METABOLITE ACTIVE -> PARENT |
PLASMA
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||